Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

58.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 76.00
  • 52 Week Low: 54.40
  • Currency: UK Pounds
  • Shares Issued: 420.70m
  • Volume: 92,774
  • Market Cap: £244.00m
  • Beta: 0.00

Niox Group Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

CEO: Jonathan Emms
CFO: Sarah Duncan
Independent Non-Executive Director: Sharon Curran
Non-Executive Chairman: Ian Johnson
Senior Independent Director: Garry Watts
Non-Executive Dir: Nicholas Mills, Robert (Rob) Graham Naylor

Contact Details

Address: Magdalen Centre, 1 Robert Robinson Ave, The Oxford Science Park, Oxford, England, United Kingdom, OX4 4GA
Phone: +44 (0)3303 309 356
Fax: +44 (0)7092 987560
Website: http://www.niox.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Niox Group Market Data

Currency UK Pounds
Share Price 58.00p
Change Today -1.00p
% Change -1.69 %
52 Week High 76.00
52 Week Low 54.40
Volume 92,774
Shares Issued 420.70m
Market Cap £244.00m
Beta 0.00

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.76% below the market average90.76% below the market average90.76% below the market average90.76% below the market average90.76% below the market average
75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average
Price Trend
43.24% above the market average43.24% above the market average43.24% above the market average43.24% above the market average43.24% above the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Income
83.52% below the market average83.52% below the market average83.52% below the market average83.52% below the market average83.52% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
47.07% above the market average47.07% above the market average47.07% above the market average47.07% above the market average47.07% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Final
Ex-Div 21-May-26 15-May-25
Paid 22-Jun-26 16-Jun-25
Amount 1.55p 1.25p

Trades for 28-May-2026

Time Volume / Share Price
13:17 10,000 @ 58.35p
13:14 9,334 @ 58.35p
13:14 5 @ 58.00p
13:14 59 @ 58.00p
13:14 2,947 @ 58.00p

Niox Group Key Personnel

CEO Jonathan Emms
CFO Sarah Duncan

Top of Page